Ownership history in CITIGROUP INC · 8 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in TSCAN THERAPEUTICS INC (TCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 1,088 | -10,684 | -90.8% | 0.00% | $2K | $1.82 |
| 2025 Q2 | REDUCED | 11,772 | -16,374 | -58.2% | 0.00% | $17K | $1.45 |
| 2025 Q1 | REDUCED | 28,146 | -12,097 | -30.1% | 0.00% | $39K | $1.38 |
| 2024 Q4 | ADDED | 40,243 | +12,450 | +44.8% | 0.00% | $122K | $3.04 |
As of 2025 Q4 — sorted by position size